Charlottesville, VA / Storyteller / Jul 27, 2026 /
PS Fertility released a new educational resource in recognition of World IVF Day that explains why male fertility evaluation should occur before beginning in vitro fertilization (IVF). The article outlines the role of male-factor infertility, describes limitations of conventional semen analysis, reviews evidence surrounding varicocele repair, and explains how sperm competency testing can provide physicians and patients with additional information before fertility treatment decisions are made.
Key Data
● Announcement: PS Fertility released a new educational article, World IVF Day 2026: What Couples Should Know About Male Fertility Before Starting Their Journey, in recognition of World IVF Day on July 25, 2026.
● What’s covered: The article explains the limitations of standard semen analysis, the importance of evaluating sperm competency, and why earlier male fertility assessment can help inform treatment planning.
● Why it matters: Male-factor infertility contributes to approximately 50% of infertility cases, yet many men receive only a conventional semen analysis before IVF.
● Diagnostic insight: PS Detect measures phosphatidylserine (PS)—a biomarker associated with sperm competency—and provides a PS Score that complements traditional semen analysis.
● Clinical relevance: Varicocele affects more than 41% of infertile men and is one of the most common, yet frequently overlooked, causes of male infertility.
● Timing consideration: Because sperm require approximately three months to mature following varicocele repair, earlier evaluation may provide couples with additional treatment options before IVF or ICSI.
● Primary audiences: Couples considering IVF, reproductive endocrinologists, reproductive urologists, fertility clinics, and other fertility care providers seeking a more comprehensive approach to male fertility evaluation.
How does evaluating male fertility before IVF help?
Couples benefit from understanding both partners’ fertility before beginning IVF. Earlier identification of male fertility factors may provide physicians with additional information when discussing treatment strategies and timing.
“IVF gives hope to countless families every year, but it’s important that couples enter the process with the most complete picture possible,” said Kevin Combs, Chief Executive Officer of PS Fertility. “Our goal is to help couples uncover potential answers earlier so they can make informed decisions alongside their physicians.”
How does PS Detect differ from a traditional semen analysis?
Traditional semen analysis evaluates sperm count, movement, and morphology. PS Detect measures phosphatidylserine (PS), a biomarker associated with sperm competency, providing physicians with complementary information that may not be captured through standard semen analysis alone.
Why is timing important when evaluating male fertility?
Some causes of male infertility, including varicocele, may be identified before IVF begins. Because sperm development takes approximately three months following treatment, earlier evaluation may provide couples and physicians with additional options during fertility planning.
“When couples have a better understanding of male fertility before beginning IVF, they have more opportunities to discuss personalized treatment options with their care team,” Combs said. “That knowledge can make an important difference as they plan the next steps in their fertility journey.”
Learn more
Read the full article, World IVF Day 2026: What Couples Should Know About Male Fertility Before Starting Their Journey, at https://psfertility.com/world-ivf-day-2026-what-couples-should-know-about-male-fertility-before-starting-their-journey/.
About PS Fertility
PS Fertility develops diagnostic tools that help physicians and patients better understand male fertility. Its flagship diagnostic, PS Detect, measures phosphatidylserine (PS) to provide additional insight into sperm competency alongside conventional semen analysis, supporting more informed fertility evaluation and treatment planning. For more information, visit www.psfertility.com.
###
Media Contact
Sydney Cheek
TwoTone Creative
sydney@twotonecreative.com
515.864.6657
LinkedIn: https://www.linkedin.com/company/ps-fertility-inc
Disclaimer: This press release is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individuals concerned about fertility should consult a qualified healthcare professional. The information presented is not intended to replace professional medical evaluation or individualized clinical guidance. Product availability and regulatory status may vary by jurisdiction.
